Sichuan Kelun Pharmaceutical Co.Ltd(002422) : Sichuan Kelun Pharmaceutical Co.Ltd(002422) public offering of convertible corporate bonds online roadshow announcement

Securities code: Sichuan Kelun Pharmaceutical Co.Ltd(002422) securities abbreviation: Sichuan Kelun Pharmaceutical Co.Ltd(002422) Announcement No.: 2022020 Sichuan Kelun Pharmaceutical Co.Ltd(002422)

Announcement on online roadshow of public issuance of convertible corporate bonds

Sponsor (lead underwriter): Changjiang Securities Company Limited(000783) underwriting sponsor Co., Ltd

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.

Sichuan Kelun Pharmaceutical Co.Ltd(002422) (hereinafter referred to as ” Sichuan Kelun Pharmaceutical Co.Ltd(002422) ” or “the issuer”) has obtained the approval of China Securities Regulatory Commission (CSRC) zjxk [2022] No. 255 for the public issuance of 300 million yuan of convertible corporate bonds (hereinafter referred to as “this issuance”).

The convertible corporate bonds issued this time are preferentially placed to the original shareholders registered by China Securities Depository and Clearing Corporation Limited Shenzhen Branch after the closing of the market on the equity registration date. The balance after the priority placement of the original shareholders (including the part that the original shareholders give up the priority placement) is issued to the public investors online through the trading system of Shenzhen Stock Exchange.

The issuance announcement of this offering has been published in the securities times, Shanghai Securities News, China Securities News and Securities Daily on March 16, 2022 (T-2). The full text of the prospectus and relevant materials can be found on cninfo.com( http://www.cn.info.com.cn. )Query.

In order to facilitate investors to understand the relevant information of Sichuan Kelun Pharmaceutical Co.Ltd(002422) this public offering of convertible corporate bonds and the relevant arrangements of this offering, the issuer and the sponsor (lead underwriter) Changjiang Securities Company Limited(000783) underwriting sponsor Co., Ltd. will hold an online roadshow on this offering, which please pay attention to.

1、 Online roadshow time: 14:00-16:00, March 17, 2022 (Thursday)

2、 Online roadshow website: China Securities Journal · China Securities Network( http://www.cs.com.cn. )

3、 Participants: key members of the issuer’s management and relevant personnel of the sponsor (lead underwriter). Issuer: Sichuan Kelun Pharmaceutical Co.Ltd(002422) sponsor (lead underwriter): Changjiang Securities Company Limited(000783) underwriting sponsor Co., Ltd. March 16, 2022

Issuer: Sichuan Kelun Pharmaceutical Co.Ltd(002422) mm / DD / yyyy (this page has no text and is the seal page of the announcement on the online roadshow of Sichuan Kelun Pharmaceutical Co.Ltd(002422) public offering of convertible corporate bonds)

Sponsor (lead underwriter): Changjiang Securities Company Limited(000783) underwriting sponsor Co., Ltd. mm / DD / yyyy

- Advertisment -